Similarly, miR‐214 targets CTNNB1, a critical component of the Wnt pathway, and downregulation of CTNNB1 by miR‐214 reduces cell invasiveness and metastatic potential in melanoma [16]. This evidence concerns the gene CTNNB1 and melanoma.